Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot

Published on 4 Dec 2023 on Fortune

The deal for three experimental medicines in obesity and diabetes could push the Swiss drugmaker...

Read the rest of the article

Start tracking your investments with Statfolio

For Immediate Release Chicago, IL – May 6, 2024 – Zacks.com announces the list of stocks featured...

Zacks via Yahoo Finance 6 hours ago

Insight into the Fund's Latest Investment Decisions and Stock Adjustments Vanguard Health Care Fu...

GuruFocus.com via Yahoo Finance 3 May 2024

Thursday, May 3, 2024The Zacks Research Daily presents the best research output of our analyst te...

Zacks via Yahoo Finance 3 May 2024

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

WTNH-TV New Haven 3 May 2024

Insatiable demand for weight-loss drugs has made the market so feverish that any positive mention...

Indianapolis Business Journal 3 May 2024

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

FOX 4 Kansas City 3 May 2024

(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity d...

Bloomberg via Yahoo Finance 3 May 2024

AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC miss...

Insider Monkey via Yahoo Finance 30 Apr 2024

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, B...

Benzinga via Yahoo Finance 29 Apr 2024

Silence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA interference...

Investing.com 29 Apr 2024